After understanding a little bit how advertisements work, I thought it would be interesting as a research topic for Unit 3 for anyone who is interested in understanding how a drug is developed and entered into marketing. Drug discovery (Drug design) is definitely not a simple process: it is extremely expensive, heavily regulated, and time-consuming. According to this article (there are arrows at the bottom of the site to see more slides), lots of drugs are actually being discovered, but only a small percentage of them pass certain efficacy criteria, and a percentage of that pass safety criteria, and a percentage of that pass the review process. After so much regulation, a drug past several years down the road may often be rejected and the process begins all over again. In addition, after clinical trials, there are another set of marketing regulations, which we talked about in class. This process brings up a lot of questions. Should pharmaceuticals be that highly regulated by FDA? From a business perspective, this regulation inhibits a lot of prospective companies from reaching their full potentials with the drugs, ethically – there might be some drugs that are effective, but not stable. And from a citizen’s perspective, the healthfulness of people comes first. Then how much governmental regulation should occur?
No comments:
Post a Comment